Francisco Ruiz-Cabello
Francisco Ruiz-Cabello
Universidad de Granada, Departamento de Bioquímica y Biología Molecular III/Inmunología
Verified email at
Cited by
Cited by
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
F Garrido, F Ruiz-Cabello, T Cabrera, JJ Perez-Villar, M López-Botet, ...
Immunology today 18 (2), 89-95, 1997
Natural history of HLA expression during tumour development
F Garrido, T Cabrera, A Concha, S Glew, F Ruiz-Cabello, PL Stern
Immunology today 14 (10), 491-499, 1993
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape
I Algarra, A García-Lora, T Cabrera, F Ruiz-Cabello, F Garrido
Cancer Immunology, Immunotherapy 53 (10), 904-910, 2004
Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment
A Serrano, S Tanzarella, I Lionello, R Mendez, C Traversari, ...
International journal of cancer 94 (2), 243-251, 2001
Analysis of HLA-E expression in human tumors
R Marín, F Ruiz-Cabello, S Pedrinaci, R Méndez, P Jiménez, ...
Immunogenetics 54 (11), 767-775, 2003
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 …
CM Cabrera, P Jimenez, T Cabrera, C Esparza, F Ruiz‐Cabello, ...
Tissue antigens 61 (3), 211-219, 2003
HLA class I antigens in human tumors
F Garrido, T Cabrera, MA Lopez-Nevot, F Ruiz-Cabello
Advances in cancer research 67, 155-195, 1995
Role of altered expression of HLA class I molecules in cancer progression
N Aptsiauri, T Cabrera, R Mendez, A Garcia-Lor, F Ruiz-Cabello, ...
Immune-Mediated Diseases, 123-131, 2007
Mutations of the β2microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides
R Benitez, D Godelaine, MA Lopez‐Nevot, F Brasseur, P Jimenez, ...
Tissue antigens 52 (6), 520-529, 1998
Multiple mechanisms underlie HLA dysregulation in cervical cancer
CS Brady, JS Bartholomew, DJ Burt, MF Duggan‐Keen, S Glenville, ...
Tissue antigens 55 (5), 401-411, 2000
MHC class I antigens and immune surveillance in transformed cells
N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ...
International review of cytology 256, 139-189, 2007
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas
MA Lopez-Nevot, F Esteban, A Ferron, J Gutierrez, MR Oliva, C Romero, ...
British journal of cancer 59 (2), 221-226, 1989
Analysis of HLA expression in human tumor tissues
T Cabrera, M López-Nevot, J Gaforio, F Ruiz-Cabello, F Garrido
Cancer Immunology, Immunotherapy 52 (1), 1-9, 2003
Presence of HPV 16 sequences in laryngeal carcinomas
M Perez‐Ayala, F Ruiz‐Cabello, F Esteban, A Concha, M Redondo, ...
International journal of cancer 46 (1), 8-11, 1990
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors
P Jiménez, J Cantón, A Collado, T Cabrera, A Serrano, LM Real, A García, ...
International journal of cancer 83 (1), 91-97, 1999
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer
JM Romero, P Jiménez, T Cabrera, JM Cózar, S Pedrinaci, M Tallada, ...
International journal of cancer 113 (4), 605-610, 2005
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
R Carretero, JM Romero, F Ruiz-Cabello, I Maleno, F Rodriguez, ...
Immunogenetics 60 (8), 439, 2008
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas
T Cabrera, A Collado, MA Fernandez, A Ferron, J Sancho, ...
Tissue antigens 52 (2), 114-123, 1998
Incidence and characteristics of CD4 (+)/HLA DRhi dendritic cell malignancies
C Bueno, J Almeida, P Lucio, J Marco, R Garcia, JM De Pablos, ...
haematologica 89 (1), 58-69, 2004
The system can't perform the operation now. Try again later.
Articles 1–20